USA CMT 1A Vit. C/Ascorbic Acid Clinical Trial in Multicenters

[Guest guest]

CMTA and MDA Co-Fund Multicenter Ascorbic Acid CMT 1A Clinical Trial

The CMTA and the MDA have joined forces to fund the first large-scale

clinical trial in North America for the most common form of CMT, CMT1A.

The CMTA has agreed to commit $550,000 over the three-year period of

the clinical trial, which will investigate the potential of high doses

of ascorbic acid to successfully treat CMT.

The research centers involved in the study will be Wayne State

University, MI, the University of Rochester, NY, and s Hopkins,

Baltimore, MD.

A more detailed description of this clinical trial along with

information for interested parties will be presented in an upcoming

issue of The CMTA Report and on the CMTA website.